18F-Fluciclovine PET/CT in Multiple Myeloma
Condition(s):Multiple Myeloma; Newly Diagnosed Multiple Myeloma (NDMM); Relapsed and/or Refractory Multiple Myeloma (RRMM)Last Updated:March 28, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Multiple Myeloma; Newly Diagnosed Multiple Myeloma (NDMM); Relapsed and/or Refractory Multiple Myeloma (RRMM)Last Updated:March 28, 2024Recruiting
Condition(s):Multiple MyelomaLast Updated:April 5, 2018Completed
Condition(s):Multiple MyelomaLast Updated:June 22, 2023Terminated
Condition(s):Multiple MyelomaLast Updated:January 3, 2024Completed
Condition(s):Multiple MyelomaLast Updated:July 17, 2020Withdrawn
Condition(s):Multiple Myeloma (MM)Last Updated:March 15, 2024Active, not recruiting
Condition(s):Multiple MyelomaLast Updated:March 16, 2021Completed
Condition(s):Multiple MyelomaLast Updated:August 1, 2023Recruiting
Condition(s):Multiple MyelomaLast Updated:October 12, 2023Terminated
Condition(s):Multiple MyelomaLast Updated:August 9, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.